Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of Parasympathetic Activity in Mild, Moderate, and Severe Asthma With Fixed Airway Obstruction

Trial Profile

Comparison of Parasympathetic Activity in Mild, Moderate, and Severe Asthma With Fixed Airway Obstruction

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Feb 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ipratropium bromide (Primary) ; Salbutamol (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms PARASYM

Most Recent Events

  • 17 Feb 2024 Status changed from not yet recruiting to recruiting.
  • 04 Oct 2023 Planned End Date changed from 30 Jun 2023 to 30 Jun 2024.
  • 04 Oct 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Jun 2024.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top